Moderate-intensity Statin vs. Individualized LDL-C Target-based Therapy in Older Adults With Type 2 Diabetes (iTARGET-Elderly Study)

NCT07359105 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

2186

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia Associated With Type II Diabetes Mellitus

Interventions

DRUG: Moderate-intensity statin monotherapy
DRUG: Ezetimibe or ezetimibe-statin combination therapy

Sponsor

Sin Gon Kim

Collaborators

[object Object]
[object Object]
[object Object]